Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AdvaMed Wary Of Japan's Ability To Improve Incremental Product Review

This article was originally published in PharmAsia News

Executive Summary

Japan is in need of device industry investment, but without the incentive of data exclusivity, the government needs to counter existing disincentives, says AdvaMed CEO.

Advertisement

Related Content

Chuikyo's Pilot For Premium Reimbursement Pricing Under Review: One Of Three Fates By Year-end
Japan To Announce Medical Device Reimbursement Cuts In Coming Weeks
Japan Rolls Out Three-Tiered Review System For Medical Devices
Japan Makes Quick Progress On Device Reviewer Hiring Pledge

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC077038

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel